During January 12-15, 2020, we were invited to participate in the annual J.P. Morgan Healthcare Conference , the most recognized medical and health investment conference in the world. The event invites Fortune 500 companies from various fields, such as pharmaceuticals, medical devices, medical services, etc. Well-known start-up companies, universities, research institutions and investment funds are also in attendance. We were able to identify and establish communications with a number of potential future collaborators at this conference.
On January 16, 2020, we participated in a project exhibition held by Sino-American Biotechnology and Pharmaceutical Professionals Association (SABPA), which showcased 20 innovative startups from San Diego, Los Angeles, San Francisco, Boston and other regions. As a result, we are advancing due diligence discussions with a number of promising startups.
In February 2020, we participated in the industry event held by ULP, an industry organization from UC Irvine. Representatives from Edwards Lifesciences, Metronic, Johnson & Johnson and other industry strategics were invited to attend. Through this event, we formed a strategic partnership with ULPto identify high-quality investment opportunities.
At the beginning of March 2020, we participated in the Healthcare Innovation event organized by UCLA’s Technology Development Group (TDG) to showcase innovative projects from UCLA School of Medicine and other institutions. Through this event, we formed a strategic partnership with TDG.
In March 2020, we completed the investment in Deepvoxel. The company uses AI to auto-contour organs-at-risk (OARs) on CT images in radiotherapy, which is the leading technology in this field in the United States.
In March 2020, we cooperated with Deloitte to provide support and services for the listing of the fund’s projects.
In May 2020, we completed the investment in Carlsmed. The company provides personalized 3D-printed spinal deformity treatment for adults and is a world-leading company in the field of orthopedics.
At the beginning of August 2020, we participated in Ophthalmology Technology Summit 2020 organized by OCTANe. This conference invited experts in the ophthalmology field to introduce the trend of future technology development and also dozens of companies with unique technologies to showcase. We actively promoted collaboration with various innovative startups at this conference.
In August 2020, we participated in the startup exhibition held by MedTech Innovator. This institution is a professional association focusing on medical devices, bringing together 60 high-quality startup companies from various medical fields, such as cardiology, diagnostic imaging, etc., to provide a large number of high-quality investment opportunities.